Medicamen Organics (NSE:MEDIORG) Enterprise Value : ₹360.3 Mil (As of Mar. 27, 2025)

Medicamen Organics Enterprise Value Chart

Competitive Comparison of Medicamen Organics's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Medicamen Organics's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicamen Organics's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicamen Organics's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Medicamen Organics's Enterprise Value falls into.

Medicamen Organics Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Medicamen Organics's Enterprise Value for the fiscal year that ended in Mar. 2024 is calculated as

Medicamen Organics's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicamen Organics  (NSE:MEDIORG) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Medicamen Organics's EV-to-EBIT for today is

Medicamen Organics's current Enterprise Value is ₹360.3 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medicamen Organics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹40.1 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Medicamen Organics's EV-to-EBITDA for today is:

Medicamen Organics's current Enterprise Value is ₹360.3 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medicamen Organics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₹47.3 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Medicamen Organics's EV-to-Revenue for today is:

Medicamen Organics's current Enterprise Value is ₹360.3 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medicamen Organics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹252.7 Mil.

4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Medicamen Organics's EV-to-FCF for today is:

Medicamen Organics's current Enterprise Value is ₹360.3 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medicamen Organics's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-40.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicamen Organics Enterprise Value Related Terms

Thank you for viewing the detailed overview of Medicamen Organics's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicamen Organics Business Description